Axa S.A. Macrogenics Inc Transaction History

Axa S.A.

  • $32.3 Billion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Feb 14, 2023
SELL
$2.25 - $9.99 $122,062 - $541,957
-54,250 Reduced 28.64%
135,150 $398,000
Q2 2022

Aug 15, 2022
SELL
$2.25 - $9.99 $122,062 - $541,957
-54,250 Reduced 28.64%
135,150 $399,000
Q1 2022

Feb 14, 2023
BUY
$8.12 - $16.9 $440,509 - $916,824
54,250 Added 40.14%
189,400 $1.67 Million
Q1 2022

May 13, 2022
BUY
$8.12 - $16.9 $1.41 Million - $2.94 Million
174,200 Added 1146.05%
189,400 $1.67 Million
Q4 2021

Feb 14, 2022
SELL
$15.91 - $21.88 $1.14 Million - $1.57 Million
-71,700 Reduced 82.51%
15,200 $244,000
Q3 2021

Nov 15, 2021
SELL
$19.74 - $28.7 $309,918 - $450,590
-15,700 Reduced 15.3%
86,900 $1.82 Million
Q2 2021

Aug 13, 2021
SELL
$20.49 - $35.63 $1.41 Million - $2.45 Million
-68,800 Reduced 40.14%
102,600 $2.76 Million
Q1 2021

May 14, 2021
BUY
$18.99 - $33.2 $2.86 Million - $4.99 Million
150,400 Added 716.19%
171,400 $5.46 Million
Q4 2020

Feb 12, 2021
BUY
$19.41 - $26.0 $407,610 - $546,000
21,000 New
21,000 $480,000
Q3 2020

Nov 13, 2020
SELL
$24.69 - $31.6 $795,018 - $1.02 Million
-32,200 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$5.2 - $29.12 $747,760 - $4.19 Million
-143,800 Reduced 81.7%
32,200 $899,000
Q3 2019

Nov 14, 2019
SELL
$12.44 - $17.48 $29,856 - $41,952
-2,400 Reduced 1.35%
176,000 $2.25 Million
Q2 2019

Aug 13, 2019
BUY
$14.51 - $19.71 $1.6 Million - $2.17 Million
110,026 Added 160.92%
178,400 $3.03 Million
Q4 2018

Feb 13, 2019
SELL
$11.75 - $21.42 $78,725 - $143,514
-6,700 Reduced 8.92%
68,374 $868,000
Q3 2018

Nov 08, 2018
BUY
$19.26 - $23.46 $1.08 Million - $1.31 Million
55,874 Added 291.01%
75,074 $1.61 Million
Q2 2018

Aug 13, 2018
BUY
$19.78 - $24.67 $379,776 - $473,664
19,200 New
19,200 $396,000
Q4 2017

Feb 13, 2018
SELL
$16.19 - $20.3 $229,898 - $288,260
-14,200 Closed
0 $0
Q3 2017

Nov 13, 2017
BUY
$15.52 - $18.94 $220,384 - $268,948
14,200
14,200 $262,000

Others Institutions Holding MGNX

# of Institutions
132
Shares Held
55.4M
Call Options Held
215K
Put Options Held
238K
View Full List

About MACROGENICS INC

MGNX Quotes by TradingView
  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $200M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email